Edition:
United Kingdom

Aetna Inc (AET.N)

AET.N on New York Stock Exchange

205.97USD
4:59pm GMT
Change (% chg)

$1.97 (+0.97%)
Prev Close
$204.00
Open
$204.64
Day's High
$206.01
Day's Low
$204.64
Volume
158,323
Avg. Vol
514,578
52-wk High
$210.79
52-wk Low
$166.92

Latest Key Developments (Source: Significant Developments)

Aetna Inc - James Clark Appointed As CVS Health’S Senior Vice President
Tuesday, 20 Nov 2018 

Nov 20 (Reuters) - Aetna Inc ::AETNA INC - ON NOV 19, CVS HEALTH ANNOUNCED EVA C. BORATTO HAS BEEN APPOINTED EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER.AETNA INC - CVS HEALTH APPOINTED JAMES D. CLARK HAS BEEN APPOINTED AS CVS HEALTH’S SENIOR VICE PRESIDENT.  Full Article

Aetna Inc Says Will Reimburse For Use Of Exparel In Ambulatory Surgical Centers In Florida And New Jersey
Tuesday, 30 Oct 2018 

Oct 30 (Reuters) - Pacira Pharmaceuticals Inc ::AETNA OFFERS EXPANDED COVERAGE FOR EXPAREL® IN SELECT AMBULATORY SURGICAL CENTERS.AETNA INC SAYS WILL REIMBURSE FOR USE OF EXPAREL IN AMBULATORY SURGICAL CENTERS IN FLORIDA AND NEW JERSEY AS PART OF A PILOT PROGRAM.AETNA - PURPOSE OF PILOT PROGRAM IS TO "INCENTIVIZE USE OF NON-OPIOID THERAPIES" FOR POSTSURGICAL PAIN MANAGEMENT IN AMBULATORY SURGICAL CENTERS.  Full Article

Aetna Reports Third-Quarter 2018 Results
Tuesday, 30 Oct 2018 

Oct 30 (Reuters) - Aetna Inc ::AETNA REPORTS THIRD-QUARTER 2018 RESULTS.Q3 ADJUSTED EARNINGS PER SHARE $2.96.Q3 EARNINGS PER SHARE $3.03.Q3 REVENUE $15.5 BILLION VERSUS I/B/E/S VIEW $15.29 BILLION.Q3 EARNINGS PER SHARE VIEW $2.83 -- THOMSON REUTERS I/B/E/S.AETNA REPORTS THIRD-QUARTER 2018 RESULTS.MEDICAL MEMBERSHIP TOTALED 22.1 MILLION AT SEPTEMBER 30, 2018.AETNA - GIVEN PENDING TRANSACTION WITH CVS HEALTH, CO IS NOT HOSTING A CONFERENCE CALL IN CONJUNCTION WITH ITS THIRD-QUARTER 2018 EARNINGS RELEASE.QTRLY TOTAL HEALTH CARE MEDICAL BENEFIT RATIO 81.5 PERCENT VERSUS 81.9 PERCENT.  Full Article

CVS Health Enters Into 364-Day Bridge Term Loan Agreement
Friday, 26 Oct 2018 

Oct 26 (Reuters) - CVS Health Corp ::CVS HEALTH CORP - ENTERED INTO A 364-DAY BRIDGE TERM LOAN AGREEMENT.CVS HEALTH - BRIDGE TERM LOAN AGREEMENT PROVIDES FOR TOTAL COMMITMENTS IN AMOUNT OF $4.0 BILLION.CVS HEALTH - BRIDGE TERM LOAN AGREEMENT ENTERED IN CONNECTION WITH PROPOSED MERGER WITH AETNA.  Full Article

Teamsters Local 727 Says Letters To Executives Get Aetna Response
Monday, 22 Oct 2018 

Oct 22 (Reuters) - TEAMSTERS LOCAL 727::LETTERS TO EXECUTIVES GET AETNA RESPONSE.TEAMSTERS LOCAL 727 AND CVS ARE NEXT SCHEDULED TO MEET ON NOV. 14.AETNA OPENED AN INVESTIGATION INTO LOCAL 727'S REPORTS OF CVS "DEFLECTING" ATTEMPTS TO BARGAIN IN "GOOD FAITH" WITH UNION.  Full Article

Aetna Announces New CEO To Lead Payflex
Monday, 1 Oct 2018 

Oct 1 (Reuters) - Aetna Inc ::AETNA ANNOUNCES NEW CHIEF EXECUTIVE OFFICER TO LEAD PAYFLEX.AETNA - HAS NAMED MICHAEL A. DISIMONE AS NEW PRESIDENT AND CEO OF PAYFLEX.  Full Article

Aetna Inc - Entered Into Asset Purchase Agreement With Subsidiary Of Wellcare Health Plans Inc
Thursday, 27 Sep 2018 

Sept 27 (Reuters) - Aetna Inc ::AETNA INC - ENTERED INTO ASSET PURCHASE AGREEMENT AND RELATED AGREEMENTS WITH A SUBSIDIARY OF WELLCARE HEALTH PLANS, INC..AETNA SAYS WELLCARE HAS AGREED TO ACQUIRE AETNA’S ENTIRE STANDALONE MEDICARE PART D PRESCRIPTION DRUG PLAN BUSINESS.AETNA SAYS PURCHASE PRICE OF DEAL IS NOT MATERIAL TO CO - SEC FILING.AETNA - BELIEVES DIVESTITURE IS A SIGNIFICANT STEP TOWARD COMPLETING DOJ'S REVIEW OF CVS HEALTH TRANSACTION.AETNA - CO, CVS HEALTH CONTINUE TO ENGAGE IN DISCUSSIONS WITH DOJ; CO'S EXPECTATIONS OF TIMING OF CLOSING OF CVS HEALTH DEAL REMAIN UNCHANGED.AETNA - CLOSING OF DIVESTITURE IS SUBJECT TO CLOSING OF CVS HEALTH'S PROPOSED ACQUISITION OF CO.AETNA - DIVESTITURE DOES NOT AFFECT AETNA'S INDIVIDUAL OR GROUP MEDICARE ADVANTAGE, MEDICARE ADVANTAGE PART D OR MEDICARE SUPPLEMENT PRODUCTS OR PLANS.  Full Article

CVS Health Q2 Adjusted Earnings Per Share $1.69
Wednesday, 8 Aug 2018 

Aug 8 (Reuters) - Cvs Health Corp ::CVS HEALTH REPORTS SECOND QUARTER RESULTS.Q2 ADJUSTED EARNINGS PER SHARE $1.69.Q2 GAAP LOSS PER SHARE $2.52 FROM CONTINUING OPERATIONS.Q2 SAME STORE SALES ROSE 5.9 PERCENT.Q2 EARNINGS PER SHARE VIEW $1.61 -- THOMSON REUTERS I/B/E/S.SEES FY ADJUSTED EARNINGS PER SHARE $6.98 TO $7.08.SEES Q3 ADJUSTED EARNINGS PER SHARE $1.68 TO $1.73.SEES FY GAAP EARNINGS PER SHARE $1.40 TO $1.50 FROM CONTINUING OPERATIONS.SEES Q3 GAAP EARNINGS PER SHARE $1.29 TO $1.34.Q2 REVENUE ROSE 2.2 PERCENT TO $46.7 BILLION.SAME STORE SALES INCREASED 5.9% AND PHARMACY SAME STORE SALES INCREASED 8.3% IN THREE MONTHS ENDED JUNE 30.FRONT STORE SAME STORE SALES DECLINED 1.0% IN THREE MONTHS ENDED JUNE 30, 2018, COMPARED TO SAME QUARTER OF PRIOR YEAR.AETNA TRANSACTION IS EXPECTED TO CLOSE DURING Q3 OR EARLY PART OF Q4 OF 2018.QTRLY RESULTS INCLUDED $3.9 BILLION GOODWILL IMPAIRMENT CHARGE RELATED TO LTC BUSINESS.CVS HEALTH - GOT A SECOND REQUEST FOR INFORMATION ABOUT AETNA DEAL FROM U.S. DOJ ON FEB 1.CVS HEALTH - REGULATORY APPROVAL PROCESS FOR AETNA DEAL PROCEEDING WITHIN A TIMEFRAME "CONSISTENT WITH EXPECTATIONS".QTRLY OPERATING LOSS INCLUDES $39 MILLION IN TRANSACTION & INTEGRATION COSTS RELATED TO PROPOSED ACQUISITION OF AETNA INC.CVS HEALTH - LTC BUSINESS CONTINUED TO FACE CHALLENGES IMPACTING ITS ABILITY TO GROW AT ESTIMATED RATE.RECEIVED APPROVAL FOR AETNA DEAL FROM A "SUBSTANTIAL" NUMBER OF STATES AND MORE ARE EXPECTED TO APPROVE THIS SUMMER.  Full Article

Aetna Q2 Earnings Per Share $3.67
Thursday, 2 Aug 2018 

Aug 2 (Reuters) - Aetna Inc ::AETNA REPORTS SECOND-QUARTER 2018 RESULTS.QTRLY TOTAL REVENUE $15,561 MILLION VERSUS $15,523 MILLION."DISCIPLINED PRICING AND MODERATE MEDICAL COST TREND CONTRIBUTED TO OUR STRONG Q2 RESULTS".Q2 ADJUSTED EARNINGS PER SHARE $3.43.Q2 EARNINGS PER SHARE $3.67.Q2 REVENUE $15.6 BILLION VERSUS I/B/E/S VIEW $15.5 BILLION.Q2 EARNINGS PER SHARE VIEW $3.04 -- THOMSON REUTERS I/B/E/S.QTRLY HEALTH CARE MEDICAL BENEFIT RATIO 79.7 PERCENT VERSUS 80.0 PERCENT.AETNA - GIVEN PENDING TRANSACTION WITH CVS HEALTH, AETNA IS NOT HOSTING A CONFERENCE CALL IN CONJUNCTION WITH ITS SECOND-QUARTER 2018 EARNINGS RELEASE.RECORDED TRANSACTION-RELATED COSTS DURING THREE & SIX MONTHS ENDED JUNE 30, 2018 RELATED TO PROPOSED ACQUISITION BY CVS HEALTH CORPORATION.  Full Article

U.S. DOJ Wont Challenge Aetna, CVS Deal - CNBC, Citing Report
Thursday, 12 Jul 2018 

July 12 (Reuters) - :U.S. DOJ WONT CHALLENGE AETNA, CVS DEAL - CNBC, CITING REPORT.  Full Article

UPDATE 2-Walgreens, Humana in talks to take stakes in each other - WSJ

Nov 20 Drugstore owner Walgreens Boots Alliance Inc and health insurer Humana Inc are in preliminary discussions to take equity stakes in each other, the Wall Street Journal reported https://www.wsj.com/articles/walgreens-humana-are-in-preliminary-talks-to-take-stakes-in-each-other-1542746915?tesla=y&mod=breakingnews on Tuesday, citing people familiar with the matter.